Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:26:01.738Z.
Calculation as of: 2026-10-06T14:26:01.738Z.
Quote observation: 2026-10-06T14:25:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3328ed161ff00c537a80d7dceb604f662f1c22c4e65cb57a824bf36ce3bbbe60
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Corvus Pharmaceuticals, Inc.
Market Cap
$865.29M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$882.16M
Operating Cash Flow Yield
N/A
TTM Avg
8.30%
3Y Avg
22.27%
5Y Avg
22.27%
Market Cap
$843.53M
Operating Cash Flow Yield
N/A
TTM Avg
10.89%
3Y Avg
10.89%
5Y Avg
10.89%
Market Cap
$890.64M
Operating Cash Flow Yield
10.88%
TTM Avg
11.28%
3Y Avg
6.74%
5Y Avg
6.11%
Market Cap
$835.01M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$817.92M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$917.50M
Operating Cash Flow Yield
7.82%
TTM Avg
8.82%
3Y Avg
7.69%
5Y Avg
7.20%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corvus Pharmaceuticals, Inc. (CRVS) | $865.29M | N/A | N/A | N/A | N/A |
| Arbutus Biopharma Corp (ABUS)vs › | $882.16M | N/A | 8.30% | 22.27% | 22.27% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $843.53M | N/A | 10.89% | 10.89% | 10.89% |
| Bioventus Inc. (BVS)vs › | $890.64M | 10.88% | 11.28% | 6.74% | 6.11% |
| Beta Bionics, Inc. (BBNX)vs › | $835.01M | N/A | N/A | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $825.62M | N/A | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $818.83M | N/A | N/A | N/A | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $817.92M | N/A | N/A | N/A | N/A |
| HealthStream, Inc. (HSTM)vs › | $917.50M | 7.82% | 8.82% | 7.69% | 7.20% |
| Ardelyx, Inc. (ARDX)vs › | $809.02M | N/A | 26.54% | 24.23% | 24.23% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
